# OnCo record paper-c-144-01-lifileucel-melanoma-jco-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-c-144-01-lifileucel-melanoma-jco-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-c-144-01-lifileucel-melanoma-jco-2021" ;
  schema:name "C-144-01: lifileucel, tumour-infiltrating lymphocytes grown from a patient's own tumour, in melanoma after checkpoint inhibitors have failed"@en ;
  schema:description "Immune cells harvested from a patient's tumour, expanded in the lab and reinfused shrank melanoma in 36% of patients whose disease had progressed on PD-1 blockade, with responses that mostly lasted."@en ;
  schema:url <https://onco.cc/key-papers/paper-c-144-01-lifileucel-melanoma-jco-2021/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=C-144-01%20lifileucel%20tumor-infiltrating%20lymphocyte%20melanoma%20Sarnaik%20JCO%202021>, <https://clinicaltrials.gov/study/NCT02360579> ;
  schema:sameAs <https://doi.org/10.1200/JCO.21.00612> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Sarnaik AA, Hamid O, Khushalani NI, et al." ;
  onco:related <https://onco.cc/key-papers/paper-rohaas-til-vs-ipilimumab-nejm-2022/> ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/til-therapy/> ;
  onco:drugs <https://onco.cc/drugs/lifileucel/>, <https://onco.cc/drugs/aldesleukin/>, <https://onco.cc/drugs/cyclophosphamide/> ;
  onco:companies <https://onco.cc/companies/iovance/> ;
  onco:institutions <https://onco.cc/institutions/moffitt/>, <https://onco.cc/institutions/nci/> ;
  onco:terms <https://onco.cc/terms/tils/>, <https://onco.cc/terms/orr/> ;
  onco:trials <https://onco.cc/trials/c-144-01/> ;
  onco:people <https://onco.cc/people/amod-sarnaik/>, <https://onco.cc/people/steven-rosenberg/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-manufacturing-cell-therapy/>, <https://onco.cc/bottlenecks/b-immunotherapy-response/> ;
  onco:journals <https://onco.cc/journals/jco/> .